Tania Armstrong-Whitworth
Stock Analyst at Canaccord Genuity
(3.67)
# 3,254
Out of 12,268 analysts
147
Total ratings
42.7%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Tania Armstrong-Whitworth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $1.25 → $19 | $9.40 | +102.13% | 5 | May 21, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Initiated Coverage: Hold | $4 → $5 | $4.65 | +7.53% | 20 | May 19, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Initiated Coverage: Buy | $7.5 → $9.5 | $8.36 | +13.64% | 23 | May 8, 2026 | |
| TSXV: DMGI DMG Blockchain Solutions Inc. | Maintained: Buy | $0.62 → $0.5 | $0.32 | +56.25% | 3 | Dec 19, 2025 | |
| TSX: EXE Extendicare Inc. | Maintained: Buy | $13 → $23 | $33.32 | -32.47% | 2 | Dec 4, 2025 | |
| TSXV: BTCT Bitcoin Treasury Corporation | Maintained: Buy | $14 → $12 | $5.24 | +133.78% | 3 | Nov 14, 2025 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $9 | $10.24 | -12.11% | 5 | Sep 2, 2025 | |
| TSX: CPH Cipher Pharmaceuticals Inc. | Maintained: Hold | $13 → $14 | $16.48 | -15.05% | 4 | Aug 11, 2025 | |
| TSX: JWEL Jamieson Wellness Inc. | Reiterated: Buy | $43 → $44 | $35.19 | +23.61% | 16 | Aug 8, 2025 | |
| TSX: DHT.UN DRI Healthcare Trust | Maintained: Buy | $18 → $20 | $16.95 | n/a | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 → $3.5 | $3.47 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $2.65 | $4.05 | n/a | 18 | Jul 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.55 → $0.45 | $0.0275 | n/a | 10 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $22.50 | n/a | 12 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Buy | $3.5 → $3 | $2.02 | n/a | 14 | Jun 28, 2022 |
Satellos Bioscience Inc.
May 21, 2026
Initiated Coverage: Buy
Price Target: $1.25 → $19
Current: $9.40
Upside: +102.13%
HLS Therapeutics Inc.
May 19, 2026
Initiated Coverage: Hold
Price Target: $4 → $5
Current: $4.65
Upside: +7.53%
Knight Therapeutics Inc.
May 8, 2026
Initiated Coverage: Buy
Price Target: $7.5 → $9.5
Current: $8.36
Upside: +13.64%
DMG Blockchain Solutions Inc.
Dec 19, 2025
Maintained: Buy
Price Target: $0.62 → $0.5
Current: $0.32
Upside: +56.25%
Extendicare Inc.
Dec 4, 2025
Maintained: Buy
Price Target: $13 → $23
Current: $33.32
Upside: -32.47%
Bitcoin Treasury Corporation
Nov 14, 2025
Maintained: Buy
Price Target: $14 → $12
Current: $5.24
Upside: +133.78%
Eupraxia Pharmaceuticals Inc.
Sep 2, 2025
Maintained: Buy
Price Target: $9
Current: $10.24
Upside: -12.11%
Cipher Pharmaceuticals Inc.
Aug 11, 2025
Maintained: Hold
Price Target: $13 → $14
Current: $16.48
Upside: -15.05%
Jamieson Wellness Inc.
Aug 8, 2025
Reiterated: Buy
Price Target: $43 → $44
Current: $35.19
Upside: +23.61%
DRI Healthcare Trust
Nov 5, 2024
Maintained: Buy
Price Target: $18 → $20
Current: $16.95
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $4.25 → $3.5
Current: $3.47
Upside: n/a
Jul 4, 2024
Maintained: Buy
Price Target: $3 → $2.65
Current: $4.05
Upside: n/a
Nov 15, 2023
Maintained: Hold
Price Target: $0.55 → $0.45
Current: $0.0275
Upside: n/a
Nov 21, 2022
Maintained: Buy
Price Target: $22 → $18
Current: $22.50
Upside: n/a
Jun 28, 2022
Downgraded: Buy
Price Target: $3.5 → $3
Current: $2.02
Upside: n/a